View Single Post
Old 05-07-2009, 06:20 AM   #4
Hopeful
Senior Member
 
Join Date: Aug 2006
Posts: 3,380
?

"Of the 42,000 breast cancer patients who overexpress the HER2 growth factor receptor, <35% are responsive to treatment with the HER2-disabling antibody, called trastuzumab (Herceptin)."

I'd like to see how they arrived at this stat.

Hopeful
Hopeful is offline   Reply With Quote